Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SE Langabeer
Transcription-Mediated Amplification and Hybridisation Protection Assay to Determine BCR-ABL Transcript Levels in Patients With Chronic Myeloid Leukaemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
E19a2 BCR-ABL Fusion Transcript in Typical Chronic Myeloid Leukaemia: A Report of Two Cases
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
IPO-trimethylation of Histone H3-Lysine9associated With P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid Leukaemia
British Journal of Haematology
Hematology
Prognostic Significance of Micro RNA 150 Marker in BCR-ABL Positive Chronic Myeloid Leukaemia Patients on Imatinib Mesylate
International Journal of Contemporary Pediatrics
Incidence and Outcome of BCR‐ABL Mutated Chronic Myeloid Leukemia Patients Who Failed to Tyrosine Kinase Inhibitors
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Chronic Myeloid Leukemia With an E1a3 BCR-ABL Fusion Protein: Transformation to Lymphoid Blast Crisis
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
Acute Myeloid Leukemia With BCR/ABL Fusion Chimera
Indian Journal of Hematology and Blood Transfusion
Hematology
Detection of BCR-ABL Transcripts in Chronic Myeloid Leukemia (CML) Using a ‘Real Time’ Quantitative RT-PCR Assay
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Management of Chronic Myeloid Leukemia With BCR/ABL Inhibitors: Current Status and Future Perspectives
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
The Chronic Myelocytic Cell Line K562 Contains a Breakpoint in BCR and Produces a Chimeric BCR/C-Abl Transcript.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
